As of today (2024-05-12), Align Technology's share price is R$363.06.
Align Technology's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was R$7.86. Hence, Align Technology's Price-to-Free-Cash-Flow Ratio for today is 46.18.
The historical rank and industry rank for Align Technology's Price-to-Free-Cash-Flow or its related term are showing as below:
BSP:A1LG34'
s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 18.51 Med: 44.49 Max: 121.64
Current: 42.38
During the past 13 years, Align Technology's highest Price-to-Free-Cash-Flow Ratio was 121.64. The lowest was 18.51. And the median was 44.49.
BSP:A1LG34's Price-to-Free-Cash-Flow is ranked worse than 61.03% of 331
companies
in the Medical Devices & Instruments industry
Industry Median: 34.64
vs BSP:A1LG34: 42.38
During the past 12 months, the average Free Cash Flow per Share Growth Rate of Align Technology was 6.30% per year.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was 7.40% per year.
During the past 5 years, the average Free Cash Flow per Share Growth Rate was 4.40% per year.
During the past 10 years, the average Free Cash Flow per Share Growth Rate was 15.40% per year.
During the past 13 years, Align Technology's highest 3-Year average Free Cash Flow per Share Growth Rate was 118.00% per year. The lowest was -22.10% per year. And the median was 25.50% per year.
Align Technology Price-to-Free-Cash-Flow Historical Data
The historical data trend for Align Technology's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Align Technology's Price-to-Free-Cash-Flow
For the Medical Devices subindustry, Align Technology's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Align Technology's Price-to-Free-Cash-Flow Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Align Technology's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Align Technology's Price-to-Free-Cash-Flow falls into.
Align Technology's Share Price of today is R$363.06. Align Technology's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was R$7.86.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
Align Technology Price-to-Free-Cash-Flow Related Terms
Thank you for viewing the detailed overview of Align Technology's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Align Technology (BSP:A1LG34) Business Description
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the FDA in 1998, and it has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans and iTero scans make up over half of these scans.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BSP:A1LG34 has been successfully added to your 